These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 10368585)
1. [The induction of a septal infarct as a therapeutic alternative in hypertrophic obstructive cardiomyopathy: new observations apropos a case]. de la Torre Hernández JM; Sánchez Mata N; Riesco Riesco F; Ruiz Delgado B; Ochoteco Azcárate A; Zueco Gil J; Colman Dejean T Rev Esp Cardiol; 1999 May; 52(5):339-42. PubMed ID: 10368585 [TBL] [Abstract][Full Text] [Related]
2. [Evolution of the surgical strategy in hypertrophic cardiomyopathy: case studies of eight patients]. Joudinaud T; Flecher E; Hvass U Ann Cardiol Angeiol (Paris); 2008 Feb; 57(1):16-21. PubMed ID: 18054343 [TBL] [Abstract][Full Text] [Related]
3. Left ventricular outflow tract gradient decrease with non-surgical myocardial reduction improves exercise capacity in patients with hypertrophic obstructive cardiomyopathy. Ruzyłło W; Chojnowska L; Demkow M; Witkowski A; Kuśmierczyk-Droszcz B; Piotrowski W; Rausinska L; Karcz M; Małecka L; Rydlewska-Sadowska W Eur Heart J; 2000 May; 21(9):770-7. PubMed ID: 10739733 [TBL] [Abstract][Full Text] [Related]
4. Pericardium-covered stent for septal myocardial ablation in hypertrophic obstructive cardiomyopathy. Gaspar J; Martínez-Ríos MA; Vonderwalde C; Rosas M; Ban-Hayashi E; Eidt-Lidt G; Kuri J Catheter Cardiovasc Interv; 1999 May; 47(1):73-9. PubMed ID: 10385166 [TBL] [Abstract][Full Text] [Related]
5. Predictors of outcome after alcohol septal ablation therapy in patients with hypertrophic obstructive cardiomyopathy. Chang SM; Lakkis NM; Franklin J; Spencer WH; Nagueh SF Circulation; 2004 Feb; 109(7):824-7. PubMed ID: 14967729 [TBL] [Abstract][Full Text] [Related]
6. Alcohol septal ablation and the Brockenbrough-Braunwald phenomenon. Soon CY; Buergler JM Catheter Cardiovasc Interv; 2008 Dec; 72(7):1016-24. PubMed ID: 19021274 [No Abstract] [Full Text] [Related]
7. Left ventricular outflow tract obstruction in the presence of asymmetric septal hypertrophy and accessory mitral valve tissue treated with alcohol septal ablation. Kim MS; Klein AJ; Groves BM; Quaife RA; Salcedo EE Eur J Echocardiogr; 2008 Sep; 9(5):720-4. PubMed ID: 18490281 [TBL] [Abstract][Full Text] [Related]
8. [Percutaneous transluminal ablation of the myocardial septum by embolization of the first branch of the anterior descending coronary artery using a small amount of absolute alcohol]. Miric M; Sagic D; Popovic Z; Zlatanovic M; Vlahovic A; Vidakovic R; Bojic M Srp Arh Celok Lek; 2001; 129(7-8):199-202. PubMed ID: 11797450 [TBL] [Abstract][Full Text] [Related]
9. Non-surgical septal reduction for hypertrophic cardiomyopathy in childhood. Subash Chandra V; Jayranganth M; Shenoy AR Int J Cardiol; 2006 Jan; 106(3):355-9. PubMed ID: 16337044 [TBL] [Abstract][Full Text] [Related]
10. Permanent pacing for complete atrioventricular block after nonsurgical (alcohol) septal reduction in patients with obstructive hypertrophic cardiomyopathy. Reinhard W; Ten Cate FJ; Scholten M; De Laat LE; Vos J Am J Cardiol; 2004 Apr; 93(8):1064-6. PubMed ID: 15081461 [TBL] [Abstract][Full Text] [Related]
11. The management of hypertrophic cardiomyopathy. Seggewiss H; Gleichmann U; Faber L N Engl J Med; 1997 Jul; 337(5):349-50. PubMed ID: 9235504 [No Abstract] [Full Text] [Related]
12. Non-surgical septal myocardial reduction by coil embolization for hypertrophic obstructive cardiomyopathy: early and 6 months follow-up. Durand E; Mousseaux E; Coste P; Pillière R; Dubourg O; Trinquart L; Chatellier G; Hagège A; Desnos M; Lafont A Eur Heart J; 2008 Feb; 29(3):348-55. PubMed ID: 18203702 [TBL] [Abstract][Full Text] [Related]
13. Coil embolization of septal artery as a treatment for hypertrophic obstructive cardiomyopathy. Bahl A Indian Heart J; 2007; 59(4):382. PubMed ID: 19126950 [No Abstract] [Full Text] [Related]
14. Percutaneous transluminal septal myocardial ablation: a novel, nonsurgical treatment for symptomatic hypertrophic cardiomyopathy. Kar S; Makkar R Rev Cardiovasc Med; 2001; 2(2):97-102. PubMed ID: 12439386 [TBL] [Abstract][Full Text] [Related]
15. Effectiveness of percutaneous intervention for patients with obstructive hypertrophic cardiomyopathy and coronary artery disease. Nambi V; Buergler JM; Lakkis NM; Franklin J; Spencer WH; Nagueh SF Am J Cardiol; 2005 Aug; 96(4):580-1. PubMed ID: 16098315 [TBL] [Abstract][Full Text] [Related]
17. Comparison of dual-chamber pacing with nonsurgical septal reduction effect in patients with hypertrophic obstructive cardiomyopathy. Dimitrow PP; Podolec P; Grodecki J; Płazak W; Dudek D; Pieniazek P; Bacior B; Legutko J; Olszowska M; Kostkiewicz M; Kawecka-Jaszcz K; Tracz W; Dubiel JS Int J Cardiol; 2004 Mar; 94(1):31-4. PubMed ID: 14996471 [TBL] [Abstract][Full Text] [Related]
18. Coil embolization of septal artery as a treatment for hypertrophic obstructive cardiomyopathy. Bahl A Indian Heart J; 2008; 60(3):273. PubMed ID: 19240323 [No Abstract] [Full Text] [Related]
19. Efficacy of nonsurgical septal reduction therapy in symptomatic patients with obstructive hypertrophic cardiomyopathy and provocable gradients. Lakkis N; Plana JC; Nagueh S; Killip D; Roberts R; Spencer WH Am J Cardiol; 2001 Sep; 88(5):583-6. PubMed ID: 11524078 [No Abstract] [Full Text] [Related]
20. Takotsubo cardiomyopathy in a patient with previously undiagnosed hypertrophic cardiomyopathy with obstruction. Brabham WW; Lewis GF; Bonnema DD; Nielsen CD; O'Brien TX Cardiovasc Revasc Med; 2011; 12(1):70.e1-5. PubMed ID: 21036671 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]